You are here

Szekanecz Zoltán

Szekanecz Zoltán

Name: Szekanecz Zoltán
Affiliation: Debreceni Egyetem. Általános Orvostudományi Kar. Belgyógyászati Intézet. Reumatológiai Tanszék / University of Debrecen. Faculty of Medicine. Department of Internal Medicine. Division of Rheumatology
Other profiles: Facebook, LinkedIn, MTMT, ResearchGate
Degree
  • az orvostudományok kandidátusa, MTA (1995)
  • az MTA doktora, MTA (2001)
Profession: rheumatologist, internist, immunologist

Publication list

Uploaded publications:
741
Publications in DEA:
721
OA:
196
Date range:
1989-2024
2024
  1. Haugen, I., Felson, D., Abhishek, A., Berenbaum, F., Bierma-Zeinstra, S., Dziedzic, K., Edwards, J., Englund, M., Hermann-Eriksen, M., Herrero-Beaumont, G., Hill, C., Ishimori, M., Jonsson, H., Karjalainen, T., Leung, Y., Maheu, E., Mallen, C., Marshall, M., Moe, R., Ramonda, R., Ritschl, V., Ritt, M., Stamm, T., Szekanecz, Z., Giesen, F., Stadt, L., Meulen, C., Wittoek, R., Greibrokk, E., Laheij, H., Kloppenburg, M.: 2023 EULAR classification criteria for hand osteoarthritis.
    Ann. Rheum. Dis. [Epub ahead of print]2024.
    Journal metrics:
    D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  2. Szűcs, G., Szekanecz, Z., Szamosi, S.: Can we define difficult-to-treat systemic sclerosis?.
    Expert Rev. Clin. Immunol. [Epub ahead of print]2024.
    Journal metrics:
    Q2 Immunology (2023)
    Q2 Immunology and Allergy (2023)
  3. Zimmerman, D., Szekanecz, Z., Markovics, A., Rosenthal, K., Carambula, R., Mikecz, K.: Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.
    Front. Immunol. 15 1-13, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    Q1 Immunology and Allergy (2023)
  4. Taylor, P., Choy, E., Baraliakos, X., Szekanecz, Z., Xavier, R., Isaacs, J., Strengholt, S., Parmentier, J., Lippe, R., Tanaka, Y.: Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases.
    RHEUMATOLOGY. 63 (2), 298-308, 2024.
    Journal metrics:
    D1 Pharmacology (medical) (2023)
    D1 Rheumatology (2023)
  5. Tóth, E., Fagyas, M., Nagy, B., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
    GeroScience. 46 (2), 1561-1574, 2024.
    Journal metrics:
    Q1 Aging (2023)
    Q1 Cardiology and Cardiovascular Medicine (2023)
    D1 Complementary and Alternative Medicine (2023)
    Q1 Geriatrics and Gerontology (2023)
    D1 Veterinary (miscellaneous) (2023)
  6. Szekanecz, Z., Buch, M., Charles-Schoeman, C., Galloway, J., Karpouzas, G., Kristensen, L., Ytterberg, S., Hamar, A., Fleischmann, R.: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician.
    Nat. Rev. Rheumatol. 20 (2), 101-115, 2024.
    Journal metrics:
    D1 Rheumatology (2023)
  7. Szekanecz, Z., Szamosi, S., Benkő, S., Szűcs, G.: Monogénesen öröklődő és szerzett autoinflammatoricus betegségek.
    Orv. hetil. 165 (18), 683-697, 2024.
    Journal metrics:
    Q4 Medicine (miscellaneous) (2023)
  8. Simon, D., Kacsándi, D., Karancsiné Pusztai, A., Soós, B., Végh, E., Kerekes, G., Czókolyová, M., Szamosi, S., Szűcs, G., Prohászka, Z., Németh, P., Berki, T., Szekanecz, Z.: Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: associations with Vascular Pathophysiology.
    Int. J. Mol. Sci. 25 (6), 1-14, 2024.
    Journal metrics:
    Q2 Catalysis (2023)
    Q1 Computer Science Applications (2023)
    D1 Inorganic Chemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
    Q2 Molecular Biology (2023)
    D1 Organic Chemistry (2023)
    Q1 Physical and Theoretical Chemistry (2023)
    D1 Spectroscopy (2023)
  9. Charles-Schoeman, C., Fleischmann, R., Mysler, E., Greenwald, M., Ytterberg, S., Koch, G., Bhatt, D., Wang, C., Mikuls, T., Chen, A., Connell, C., Woolcott, J., Menon, S., Chen, Y., Lee, K., Szekanecz, Z.: Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients.
    Arthritis Rheumatol. [Epub ahead of print]2024.
    Journal metrics:
    D1 Immunology (2023)
    D1 Immunology and Allergy (2023)
    D1 Rheumatology (2023)
  10. Steiner, G., Van Hoovels, L., Csige, D., Gatto, M., Iagnocco, A., Szekanecz, Z.: Should ACR/EULAR criteria be revised changing the RF and ACPA scores?.
    Autoimmun. Rev. 23 (1), 1-5, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)
  11. Caporali, R., Germinario, S., Kacsándi, D., Choy, E., Szekanecz, Z.: Start RA Treatment - Biologics or JAK-Inhibitors?.
    Autoimmun. Rev. 23 (1), 1-4, 2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)
  12. Szekanecz, Z.: Twenty shades of the mosaic of autoimmunity.
    Autoimmun. Rev. [Epub ahead of print]2024.
    Journal metrics:
    Q1 Immunology (2023)
    D1 Immunology and Allergy (2023)
2023
  1. Szekanecz, Z.: A reumatológia elmúlt tíz éve.
    Orvostovábbk. szle. Jubileumi szám 1-7, 2023.
Show all
updated: 2024-07-17, 01:52

SCImago quartiles of
scientific journal articles

Number of scientific articles: 595
Q1/D1 73 (12.3%)
Q1 180 (30.3%)
Q2 81 (13.6%)
Q3 36 (6.1%)
Q4 28 (4.7%)
N/A 270 (45.4%)